NCT04963634View on ClinicalTrials.gov

Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema

RecruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

January 22, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Angio Edema
Interventions
OTHER

Biobanking

For patients included in BRADYDIAG study, 2 blood samples will be collected at enrollment (for group 1: bradykinin angioedema and for group 2: histamine-mediated angioedema) and at 1 year visit (for group 1 only: bradykinin angioedema).

Trial Locations (1)

59037

RECRUITING

Hop Claude Huriez Chu Lille, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER